Divisas / IMCR
IMCR: Immunocore Holdings plc - American Depositary Shares
32.34
USD
0.03
(0.09%)
El tipo de cambio de IMCR de hoy ha cambiado un 0.09%. En este caso, el precio mínimo en el mercado ha alcanzado 31.37, mientras que el máximo ha alcanzado 33.00.
Siga la dinámica de la pareja de divisas Immunocore Holdings plc - American Depositary Shares. El gráfico histórico le mostrará cómo ha cambiado el precio de %AssetName% en el pasado. Alternando entre diferentes marcos temporales, podrá monitorear las tendencias y la dinámica del tipo de cambio por minutos, horas, días, semanas y meses. Use esta información para predecir los cambios en el mercado y tomar decisiones comerciales fundamentadas.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
IMCR News
- Seeking Alpha Immunocore Holdings plc 2025 Q2 - Results - Earnings Call Presentation (NASDAQ:IMCR)
- Seeking Alpha Immunocore Holdings plc (IMCR) Q2 2025 Earnings Call Transcript
- Zacks IOVA Q2 Earnings Miss, Stock Down on EMA Filing Withdrawal for Amtagvi
- Zacks Nektar Q2 Loss Narrower Than Expected, Revenues Fall Y/Y
- Zacks Intellia Q2 Loss Narrower Than Expected, Pipeline Progress in Focus
- Zacks PBYI's Q2 Earnings Beat Estimates, Nerlynx Sales Drive Revenues
- Zacks MIRM Stock Up on Q2 Earnings and Revenue Beat, Raised 2025 View
- Zacks Viatris Stock Rises as Q2 Earnings & Revenues Beat Estimates
- Zacks Catalyst Pharmaceuticals Q2 Earnings Beat, Firdapse Revenues Rise Y/Y
- Zacks Acadia Q2 Earnings Beat, Nuplazid & Daybue Sales Drive Revenue Growth
- Zacks Compared to Estimates, Immunocore (IMCR) Q2 Earnings: A Look at Key Metrics
- Zacks ADMA Beats on Q2 Earnings and Revenues, Asceniv Drives Momentum
- Investing Immunocore Holdings earnings missed by $0.02, revenue topped estimates
- Zacks Novo Nordisk Q2 Earnings Beat, Sales Miss, GLP-1 Drugs Face US Hurdles
- Zacks HALO Stock Up on Q2 Earnings and Revenue Beat, Raised 2025 View
- Zacks BEAM's Q2 Loss Narrower Than Expected, Revenues Miss Mark
- Zacks RXRX Q2 Loss Wider Than Expected, Revenues Rise Y/Y, Stock Down
- Zacks Ultragenyx's Q2 Loss Narrower Than Expected, Revenues Rise Y/Y
- Zacks ESPR's Q2 Earnings & Revenues Trump Estimates, Stock Rises
- Zacks Perrigo Beats on Q2 Earnings & Sales, Stock Down on '25 Sales View Cut
- Zacks JAZZ Stock Down on Wider-Than-Expected Q2 Loss, '25 Sales View Cut
- Zacks ZTS Q2 Earnings & Revenues Beat Estimates, '25 Outlook Raised
- Zacks TGTX Down as Q2 Earnings Miss Mark, Briumvi Sales Drive Top Line
- Zacks CRSP Stock Down on Huge Q2 Loss, Focus on Increasing Casgevy Adoption
Rango diario
31.37
33.00
Rango anual
23.15
39.32
- Cierres anteriores
- 32.31
- Open
- 32.29
- Bid
- 32.34
- Ask
- 32.64
- Low
- 31.37
- High
- 33.00
- Volumen
- 641
- Cambio diario
- 0.09%
- Cambio mensual
- -1.88%
- Cambio a 6 meses
- 7.76%
- Cambio anual
- -8.95%
19 agosto, martes
12:30
USD
- Act.
- 1.428 M
- Pronós.
- 1.287 M
- Prev.
- 1.358 M
12:30
USD
- Act.
- 1.354 M
- Pronós.
- 1.415 M
- Prev.
- 1.393 M
12:30
USD
- Act.
- 5.2%
- Pronós.
- 3.2%
- Prev.
- 5.9%
12:30
USD
- Act.
- -2.8%
- Pronós.
- -1.8%
- Prev.
- -0.1%
18:10
USD
- Act.
- Pronós.
- Prev.